Analysts at The Goldman Sachs Group started coverage on shares of Cochlear (OTCMKTS:CHEOY - Get Free Report) in a research report issued on Thursday, Marketbeat reports. The brokerage set a "neutral" rating on the stock.
Cochlear Price Performance
Shares of CHEOY traded down $2.43 during trading hours on Thursday, reaching $94.16. The stock had a trading volume of 10,328 shares, compared to its average volume of 11,453. The firm has a 50-day simple moving average of $94.93 and a 200 day simple moving average of $99.84. Cochlear has a 12 month low of $89.39 and a 12 month high of $115.85.
Cochlear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
Before you consider Cochlear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cochlear wasn't on the list.
While Cochlear currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
